Bayer Commits $5.6 Billion to Glyphosate Alternatives
July 7, 2019 in Articles
Bayer AG will pump about $5.6 billion dollars of its research and development budget into alternatives to its weedkiller glyphosate over the next decade.
Trying to ease concerns about the controversial compound, the German chemical and drug company said it will seek more public feedback during the coming safety certification process in Europe. Bayer wants to offer members of the green industry new products to combat weeds while standing behind glyphosate-based Roundup, which it acquired via its $63 billion purchase of Monsanto.
“While glyphosate will continue to play an important role in agriculture and in Bayer’s portfolio, the company is committed to offering more choices for growers,” a Bayer spokesperson said in a recent statement.